Assenagon Asset Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-65
| Closed | -$79K | – | 1366 |
|
|
2022
Q4 | $79K | Hold |
65
| – | – | ﹤0.01% | 1283 |
|
|
2022
Q3 | $52K | Buy |
+65
| New | +$52K | ﹤0.01% | 1259 |
|
|
2022
Q2 | – | Sell |
-15
| Closed | -$31K | – | 1408 |
|
|
2022
Q1 | $31K | Sell |
15
-187
| -93% | -$386K | ﹤0.01% | 1345 |
|
|
2021
Q4 | $991K | Sell |
202
-103
| -34% | -$505K | ﹤0.01% | 997 |
|
|
2021
Q3 | $1.92M | Sell |
305
-7
| -2% | -$44K | 0.01% | 672 |
|
|
2021
Q2 | $2.94M | Buy |
312
+168
| +117% | +$1.58M | 0.01% | 562 |
|
|
2021
Q1 | $1.25M | Buy |
+144
| New | +$1.25M | 0.01% | 824 |
|
|
2020
Q3 | – | Sell |
-40
| Closed | -$300K | – | 1079 |
|
|
2020
Q2 | $300K | Buy |
+40
| New | +$300K | ﹤0.01% | 981 |
|
|
2019
Q3 | – | Sell |
-94
| Closed | -$1.48M | – | 807 |
|
|
2019
Q2 | $1.48M | Buy |
+94
| New | +$1.48M | 0.01% | 581 |
|